Get started
Author

Swaminathan Rajaraman

Neutropenic versus regular diet for acute leukaemia induction chemotherapy: randomised controlled trial
2022 · Venkatraman Radhakrishnan, Perraju Bhaskar Bhuvan Lagudu, et al. · BMJ Supportive & Palliative Care · 17
Management outcomes of pediatric and adolescent papillary thyroid cancers with a brief review of literature
2018 · Arvind Krishnamurthy, Ravishankar Palaniappan, et al. · Indian Journal of Cancer · 17
Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial
2022 · Venkatraman Radhakrishnan, Sameer Bakhshi, et al. · Blood Cancer Journal · 13
PDF
A Glimpse into the Epidemiology of Geriatric Cancers in India: Report from the Indian Population Based Cancer Registries
2024 · Sharada Mailankody, Vishwapriya Godkhindi, et al. · Asian Pacific Journal of Cancer Prevention · 7
Assessment of Barriers and Enablers for Implementing a Population‐Based Childhood Cancer Registry in Chennai, India
2024 · Venkatraman Radhakrishnan, Ayswarya Jothi, et al. · Pediatric Blood & Cancer · 4
PDF
Linking population-based cohorts with cancer registries in LMIC: a case study and lessons learnt in India
2023 · Aastha Aggarwal, Ranganathan Rama, et al. · BMJ Open · 4
PDF
Identification of tumor biomarkers for pathological complete response to neoadjuvant treatment in locally advanced breast cancer
2022 · Prarthana Gopinath, Sridevi Veluswami, et al. · Breast Cancer Research and Treatment · 2
Olanzapine-based, dexamethasone-free antiemetic prophylaxis for highly emetogenic chemotherapy in children and adolescents: A multicenter phase III non-inferiority trial (CIVIC-POD).
2026 · Venkatraman Radhakrishnan, Prasanth Srinivasan, et al. · Journal of Clinical Oncology
Dexamethasone-free antiemetic prophylaxis with olanzapine in children and adolescents receiving highly emetogenic chemotherapy: A multicenter, phase III non-inferiority randomized trial.
2026 · Venkatraman Radhakrishnan, Prasanth Srinivasan, et al. · Journal of Clinical Oncology
Dexamethasone for 12 weeks for reducing fatigue in patients receiving palliative chemotherapy: A Phase 3, Placebo-Controlled, Randomized Controlled Trial
2025 · Venkatraman Radhakrishnan, Vidhya Gopalakrishnan, et al. · Supportive Care in Cancer
Assessment of Barriers and Enablers for Implementing a Population-Based Childhood Cancer Registry in Chennai, India
2025 · Venkatraman Radhakrishnan, Ayswarya Jothi, et al. · OncoDaily Medical Journal
PDF
Lymphocytic Host Response and other Prognostic Factors in Early Stage Squamous Cell Carcinoma of Tongue: Retrospective Analysis from a Tertiary Cancer Center
2023 · Aswin Anapathoor Nagarajan, Swaminathan Rajaraman, et al. · South Asian Journal of Cancer
PDF
Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial
2022 · Venkatraman Radhakrishnan, Sameer Bakhshi, et al. · Blood Cancer Journal
PDF
Randomized phase III trial comparing Daunorubicin and ara-C (DA) versus ara-C, Daunorubicin, and Etoposide (ADE) as induction chemotherapy in pediatric acute myeloid leukemia (InPOG-AML-16-01)
2022 · Venkatraman Radhakrishnan, Sameer Bakhshi, et al. · Pediatric Hematology Oncology Journal
PDF
Epidemiological Profile of Breast Cancer in South India: A Case-Control Study
2022 · Amritha Sathyanarayanan, Rajkumar Thangarajan, et al. · SSRN Electronic Journal
Randomized controlled trial of neutropenic diet versus regular diet in patients undergoing induction chemotherapy for acute leukemia
2022 · Venkatraman Radhakrishnan, Perraju Bhaskar Bhuvan Lagudu, et al. · Pediatric Hematology Oncology Journal
PDF
Works count: 16
Citation count: 64
H-index: 4
I10-index: 3
Year
Topic
Type